EZEugene Zeltyn-Abramov

Eugene Zeltyn-Abramov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Eugene Zeltyn-Abramov has a total of 86 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The fibrin sheath after dialysis catheter removal or the “ghost” catheter - what a surgeon, nephrologist and cardiologist needs to know?

    by City Clinical Hospital No. 52 of Moscow Healthcare Department, E.M. Zeltyn-Abramov, Pirogov Russian National Research Medical University (Pirogov Medical University), N.I. Belavina, V.I. Vtorenko

  • Prediction of COVID-19 course in patients with stage 3 chronic kidney disease and type 2 diabetes mellitus

    by N. N. Klochkova, M. A. Lysenko, Е. М. Зелтынь-Абрамов, T. N. Markova, N. G. Poteshkina, N. I. Belavina, S. V. Kondrashkina

    BACKGROUND.Patients with Diabetes Mellitus 2 (DM2) and Chronic Kidney Disease (CKD) are at a high risk for severe clinical course of COVID-19. The high mortality rate due to COVID-19 and widespread distribution of DM2 and CKD all over the world make it necessary to determine the predictors of adverse outcome of novel coronavirus infection (NCI).AIM.The identification of predictors of NCI adverse outcome in patients with DM2 and CKD stage 3 due to diabetic kidney disease.Patients and Methods. The patients with NCI and CKD stage 3 were included in observational retrospective uncontrolled study during the follow-up period from 04.01. to 10.30.2020. The study endpoints were the outcome of NCI (survivors/nonsurvivors). Data were collected from electronic versions of case records. Demographic, DM2-related, CKD-related and NCI-related baseline parameters/signs were studied as independent variables.RESULTS.90 patients with DM2 and CKD stages 3 (Me GFR 43[37; 49] ml/ min/1,73m2) were included, mean age 70 [69; 78] y, females – 56 %, the mortality rate – 21 %. The independent predictors of NCI adverse outcome were detected using a single factor analysis (odds ratio). Among them are: initial prandial glycemia ≥ 10 mmol/l (ОR 11,8; 95 % CI 3,13–44,9; р CONCLUSION. The detected predictors of adverse outcome are the part of routine screening available in pre-hospital setting and at hospital admission. Early identification of predictors allows optimizing patient routing and selecting the best treatment strategy for each patient.

  • Open Access

    Evolution of the prevalence of the cardiorenal continuum in hospitalized patients with type 2 diabetes in real clinical practice (experience of Moscow City Clinical Hospital No. 52 of Moscow Health Department)

    by M.B. Antsiferov, M.A. Lysenko, Т.N. Markova, E.M. Zeltyn-Abramov, N.I. Belavina, M.A. Ovchinnikova, A.A. Anchutina, I.A. Ivanova

    Эволюция распространенности кардиоренального континуума у госпитализированных пациентов с сахарным диабетом 2 типа в реальной клинической практике


  • Embolic kidney infarction as a clinical manifestation of benign cardiac tumor

    by Moscow City Hospital 52, I.V. Barkova, O.V. Manchenko, A.I. Kovalev, N.V. Sklifosovsky Research Institute for Emergency Medicine, A.I. Ibraeva, E.M. Zeltyn-Abramov, Moscow City Hospital 52; Pirogov Russian National Research Medical University (Pirogov Medical University)

  • COVID-19 in patients with advanced stages of diabetic kidney disease: new onset renal replacement therapy as one of the predictors of adverse outcome

    by State Budgetary Healthcare Institution “City Clinical Hospital 52” of Moscow Healthcare Department, N.N. Klochkova, Pirogov Russian National Research Medical University (Pirogov Medical University), M.A. Lysenko, State Budgetary Healthcare Institution “City Clinical Hospital 52” of Moscow Healthcare Department; Pirogov Russian National Research Medical University (Pirogov Medical University), E.M. Zeltyn-Abramov, T.N. Markova, State Budgetary Healthcare Institution “City Clinical Hospital 52” of Moscow Healthcare Department; A.I. Yevdokimov Moscow State University of Medicine and Dentistr, N.G. Poteshkina, N.I. Belavina, et al.


  • Open Access

    COVID-19-Associated Biventricular Takotsubo Syndrome Complicated with Cardiogenic Shock (Clinical Case)

    by Е. М. Зелтынь-Абрамов, N. I. Belavina, N. N. Klochkova, R. T. Iskhakov, O. Yu. Evsyukov, L. Yu. Аrtyukhina, A. M. Svanadze, M. A. Lysenko

    Среди внелегочных проявлений COVID-19 важное место занимает острая миокардиальная дисфункция. Одной из причин ее развития является синдром Такоцубо (СТ). Частота встречаемости СТ у пациентов с COVID-19 неизвестна. Представлено клиническое наблюдение пожилой пациентки с тяжелым течением COVID-19, получавшей лечение программным гемодиализом. В ходе сеанса терапевтического плазмообмена развился эпизод фибрилляции желудочков с формированием клинико-инструментальной картины кардиогенного шока, сопровождавшейся инфарктоподобными изменениями ЭКГ. По данным Эхо-КГ выявлен типичный паттерн бивентрикулярного СТ с выраженным снижением систолической функции обоих желудочков. По результатам экстренной коронароангиографии обструктивного поражения коронарного русла не выявлено. В течение последующей недели лечения отмечались полное восстановление систолической функции обоих желудочков, регресс инфарктоподобных изменений ЭКГ и разрешение кардиогенного шока. Дальнейшее течение заболевания осложнилось развитием сепсиса и полиорганной недостаточности, приведших к летальному исходу. По данным аутопсии коронарогенное и вирусное поражение миокарда были исключены. Представленный случай демонстрирует развитие жизнеугрожающего варианта СТ у пациентки с COVID-19. В качестве вероятного триггера следует рассматривать процедуру терапевтического плазмообмена.

  • The application experience of focused ultrasound heart examination in patients with COVID-19 in Prone-position

    by N. I. Belavina, R. T. Iskhakov, I. V. Barkova, Е. С. Ильина, I. A. Kesareva, N. V. Leonenko, T. A. Nikitina, I. V. Pirozhkova, N. V. Sokolova, P. A. Taymaskhanova, et al.

    Aim of the study . To study the experience of using focused transthoracic echocardiography in patients with COVID-19 in prone position (fEchoPr) in intensive care units (ICU). Materials and methods . The retrospective observational study included 53 patients (period from 15 April to 31 December 2020). Inclusion criteria: confirmed diagnosis of COVID-19, availability of fEchoPr data, outcome certainty (discharge/death). We analyzed electronic medical records. The fEchoPr was performed in patients in the prone position with a bolster under the left side of the chest and left arm raised (‘swimmer’s position’). We assessed the systolic function of the right ventricle (RV) (tricuspid annular plane systolic excursion (TAPSE)), RV size, RV/LV ratio, systolic function of the left ventricle (LV) (left ventricular outflow tract velocity time integral. (LVOT VTI)), and pulmonary hypertension (PH) (tricuspid regurgitation peak gradient (PGTR). Depending on the results, the patients were divided into 2 groups: informative (+fEchoPr) and non-informative (–fEchoPr) examinations. Results . There was no statistically significant difference in the groups (+fEcho n = 35 vs –fEcho n = 18) by age (65.6 ± 15.3 vs 60.2 ± 15.8, p > 0.05), by gender (male: 23 (65.7%) vs 14 (77.8%), p > 0.05), by body mass index (31.3 ± 5.3 kg/m 2 vs 29.5 ± 5.4 kg/m2 , p > 0.05), by mechanical ventilation support (24 (68.6%) vs 17 (94.4%), p = 0.074), by NEWS scale indicators (6.9 ± 3.7 vs 8.5 ± 3.5 points), by mortality (82.8% vs 94.4%, p > 0.05). Correlation analysis revealed a moderate inverse relationship between being on mechanical ventilation and the informative value of the study (Spearman's r = −0.30 at p = 0.033). In the +fEchoPr group, the correct measurement of TAPSE and RV/LV was carried out in 100%: a decrease in RV systolic function was recorded in 5 patients (14%), expansion of the RV in 13 patients (37%). Signs of PH were detected in 11 patients (31%), PGTR could not be measured in 10 patients (28%). LV systolic dysfunction was detected in 7 patients (20%). No pathology was detected in 16 patients (46%). One patient was diagnosed with infective endocarditis of native mitral valve, which was later confirmed by autopsy. Conclusion . In 66% of cases, fEchoPr examinations were informative, especially in terms of assessing the state of the right heart. fEchoPr examination is an affordable, valid and reproducible method to assess and monitor the state of the heart in ICU patients.

  • Open Access

    Risk factors of adverse outcome of COVID-19 and experience of Tocilizumab administration in patients on maintenance hemodialysis due to diabetic kidney disease

    by Е. М. Зелтынь-Абрамов, M. A. Lysenko, N. F. Frolova, T. N. Markova, N. I. Belavina, N. N. Klochkova, S. V. Kondrashkina, R. T. Iskhakov, A. I. Ushakova

    BACKGROUND: Patients with Type 2 Diabetes (T2DM) and patients on maintenance hemodialysis (MHD) are at a high risk of adverse clinical course of COVID-19. To date, the causes of high mortality in these groups are not fully understood. Data about peculiarity of clinical course and Tocilizumab (TCZ) administration in patients with T2DM receiving MHD due to outcome of diabetic kidney disease (DKD) are not yet highlighted in current publications.AIMS: Identification of risk factors (RF) of adverse COVID-19 outcome and evaluation of TCZ administration in patients with T2DM receiving MHD due to DKD.MATERIALS AND METHODS: The patients treated in Moscow City Hospital No52 were included in retrospective observational study. The observation period was from 04.15 to 07.30 2020. The study endpoints were the outcomes of hospitalization — discharge or lethal outcome. Data were collected from electronic medical database. The following independent variables were analysed: gender, age, body mass index, time from the onset of symptoms to hospital admission, cardiovascular and general comorbidity (Charlson Index, CCI), cardiovascular event (CVE) during hospitalization, treatment in ICU, mechanical ventilation (MV), degree of lung damage according to CT data, level of prandial glycemia at admission, MHDassociated parameters (vintage, type of vascular access, frequency of complications). The autopsy reports were evaluated for the purpose of lethal structure investigation. In a subgroup treated TCZ the time from symptoms onset to TCZ administration and number of laboratory indicators were evaluated.RESULTS: 53 patients were included, mean age 68 ±9 y, males — 49%. General mortality in observation cohort was 45%, mortality in ICU — 81%, mortality on MV — 95%. High cardiovascular and general comorbidity was revealed (mean CCI — 8,3 ±1,5 points). The causes of outcomes according to autopsy reports data: CVE 37,5% (among them — acute myocardial infarction during hospitalization), severe respiratory failure — 62,5%. The independent predictors of lethal outcome were: MV (OR 106; 95% CI 11,5–984; р CONCLUSIONS: The number of RF of adverse COVID-19 outcome in patients with T2DM receiving MHD due to DKD are identified. CVE is one of the leading causes of mortality in study cohort. According to our experience the preventive (instead of rescue) strategy of TCZ administration should be used.


  • Stress-induced cardiomyopathy in a patient with a fulminant course of covid-19 early after a kidney allotransplantation

    by E.M. Zeltyn-Abramov Zeltyn-Abramov, N.I. Belavina Belavina, N.F. Frolova Frolova, L.YU. Artyukhina Artyukhina, O.L. Podkorytova Podkorytova, V.V. Varyasin Varyasin, V.V. Parshin Parshin, I.K. Maksimov Maksimov, O.YU. Evsyukov Evsyukov, E.A. Shishchenko Shishchenko


  • P1261DIAGNOSTIC VALUE OF TEMPORARY OCCLUSION OF ARTERIO-VENOUS HIGH FLOW FISTULA DURING RIGHT HEART CATHETERISATION IN PATIENTS WITH PULMONARY HYPERTENSION

    by Eugene Zeltyn-Abramov, Rustam Iskhakov, Natalya Belavina, Nataliya Klochkova, Nadia Frolova

    Background and Aims: Pulmonary hypertension (PH) is prevalent in patients with functioning high-flow arterio-venous fistula (HFAVF) and associated with congestive heart failure (CHF). The real incidence and possible causes of this phenomenon is a matter of debate. Hemodynamic effects of HFAVF is considering as one of the reasons for PH formation. The subject of study was the impact of HFAVF on selected parameters of central hemodynamics. In particular, the diagnostic relevance of test of temporary HFAVF occlusion (TTO) was evaluated during right heart catheterization (RHC). Method: A total of 13 patients were enrolled: 8 - after kidney transplantation (KT) with preserved allograft function and 5 - on maintenance hemodialysis (HD). All of them demonstrated clinical presentation of CHF III-IV class (NYHA). Severe PH and diastolic disfunction (DD) were observed at a baseline: echocardiographic systolic pulmonary arterial pressure sPAP (mmHg): M=59 (SD 13), ratio of mitral early diastolic inflow velocity (E) (pulsed wave Doppler) to average of septal and lateral mitral annular early-diastolic peak velocity (e′) (tissue Doppler imaging) E/e′ M=18 (SD 5). The ones who have comorbid conditions that cause PH were excluded. All patients bore an upper arm HFAVF, flow of the AVF (Qa) measured by Doppler ultrasonography was markedly high (Qa): M = 3,8 l/min (SD 1,2), the cardio-pulmonary recirculation (Qa/CO): M = 51% (SD 13). All patients underwent RHC and TTO AVF. Echocardiography (Echo) was performed initially and on the follow up (8 weeks after AVF closure/flow reduction). Statistical analysis was performed using the STATISTICA 13 software (Wilcoxon, T-test). Results: The results of RHC and Echo data are presented in tables 1, 2. As can be seen from the table data, all cases demonstrated instrumental features of high output CHF (HO CHF) in accordance with patient’s clinical status. TTO of HFAVF resulted in statistically significant decrease in CO and CI values, but no changes in PAP parameters were observed. Taking into account clinical and instrumental features of advanced CHF, HF AVF was closed in 8 patients after KT and in 2 patients on HD. 3 patients on HD underwent AVF flow reduction up to Qa not exceeding 1,1 l/min. Follow-up demonstrated complete resolution of CHF and dramatic improvement of DD, reduction in CO, CI, sPAP, volume parameters. CO, cardiac output; CI, cardiac index; sPAP, systolic pulmonary arterial pressure; meanPAP, mean pulmonary arterial pressure; RAP, mean right atrial pressure; PCWP, pulmonary capillary wedge pressure; LV EDVi, left ventricular end-diastolic volume index; LAVi, left atrial volume index; RAVi, right atrial volume index; Conclusion: PH is a component of AVF-induced HO CHF and could be classified as postcapillary one. TTO confirms significant HFAVF contribution to specific changes of parameters of central hemodynamics due to HO CHF. TTO does not impact on PAP values and therefore is not valid to clarify PH genesis per se.